This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Western Equine Encephalitis Virus Spike Glycoprotein E2, N-His
Product Overview
BioVenic's Recombinant Western Equine Encephalitis Virus Spike Glycoprotein E2, N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 43.7 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The E2 glycoprotein is the primary host-cell attachment protein for WEEV, forming a heterodimer with E1 on the viral surface. It facilitates viral entry by binding to specific cellular receptors, such as heparan sulfate or the laminin receptor. As the most immunodominant surface protein, E2 contains the majority of neutralizing epitopes, making it a critical target for diagnostic assays, monoclonal antibody therapies, and the development of recombinant subunit vaccines against alphavirus infections.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
